Campbell & CO Investment Adviser LLC Sanofi Transaction History

Campbell & CO Investment Adviser LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 12, 2024	BUY	$48.54 - $58.53 $460,353 - $555,098	9,484 Added 141.49%	16,187 $933,000
Q2 2024 Aug 13, 2024	BUY	$45.39 - $50.36 $304,249 - $337,563	6,703 New	6,703 $325,000
Q3 2023 Nov 08, 2023	SELL	$50.95 - $55.2 $120,140 - $130,161	-2,358 Reduced 33.96%	4,586 $245,000
Q2 2023 Aug 11, 2023	BUY	$50.45 - $57.18 $19,877 - $22,528	394 Added 6.02%	6,944 $374,000
Q1 2023 May 11, 2023	SELL	$45.86 - $54.45 $359,037 - $426,289	-7,829 Reduced 54.45%	6,550 $356,000
Q4 2022 Feb 14, 2023	SELL	$38.86 - $48.55 $2.16 Million - $2.69 Million	-55,456 Reduced 79.41%	14,379 $696,000
Q3 2022 Nov 14, 2022	BUY	$37.22 - $100.5 $2.6 Million - $7.02 Million	69,835 New	69,835 $2.66 Million

803

266M

1.82M

1.64M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $143B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.